The role of dyslipidemia and statins in venous thromboembolism

Recent studies have proposed an association between hyperlipidemia and venous thromboembolism (VTE). We review the epidemiological evidence linking dyslipidemia with VTE and examine several possible underlying mechanisms. We discuss the possible role of HMG CoA reductase inhibitors (statins) in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Joel G, Rosendaal, Frits R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59643/
https://www.ncbi.nlm.nih.gov/pubmed/11806791
http://dx.doi.org/10.1186/cvm-2-4-165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59643/
https://www.ncbi.nlm.nih.gov/pubmed/11806791
http://dx.doi.org/10.1186/cvm-2-4-165

Ejemplares similares